Loading
institutionsInstitution
Cancer Care Alberta (Alberta Health Services)
Alberta's provincial cancer programme, anchored by Calgary's new Arthur J.E. Child Comprehensive Cancer Centre and Edmonton's Cross Cancer Institute, birthplace of the linac-MR.
Also called: Arthur J.E. Child Comprehensive Cancer CentreTom Baker Cancer CentreCross Cancer Institute
Overview
Cancer Care Alberta is the province-wide cancer programme of Alberta Health Services, running two tertiary centres, the Arthur J.E. Child Comprehensive Cancer Centre in Calgary (opened in 2024, replacing the Tom Baker Cancer Centre) and the Cross Cancer Institute in Edmonton, plus regional and community sites, the Alberta Cancer Registry and provincial screening programmes. Gino Fallone's team at the Cross Cancer Institute built the world's first prototype hybrid linear accelerator-MRI, the origin of the rotating-biplanar linac-MR concept, and Edmonton's cyclotron and PET programme was an early producer of radiotracers. Calgary's University of Calgary spawned Oncolytics Biotech's reovirus therapy, and Alberta's trial units are major contributors to the Canadian Cancer Trials Group. Provincial data systems support real-world outcome studies.
Location
Calgary, AB, CA
Type
cancer center · University of Calgary / University of Alberta
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#353 · 18 points (0 Newsweek + 0 NCI + 18 from 9 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Cancer Care Alberta, including child institutions. 122 works · 1,735 citations · 81% open access · 4% clinical trials · 4% reviews.
Oncology works per year
232022
252023
272024
262025
212026
Most works
- Margaret L. McNeely34 works
- Christine M. Friedenreich23 works
- Susan Nicole Culos-Reed19 works
- Lin Yang18 works
- Karen A. Kopciuk16 works
- Lorraine Shack14 works
- Kerry S. Courneya12 works
- Qinggang Wang12 works
- Yibing Ruan11 works
- L Capozzi11 works
Most cited
- Arthur J.E. Child Comprehensive Cancer Centre
- Cross Cancer Institute (Edmonton)
- Linac-MR development
- Provincial screening and registry
Brenda Hubley
Chair and Managing Director, Cancer Care Alberta
Radiation therapyCancer programme leadershipHealth services management
Radiation therapist turned health executive who leads Cancer Care Alberta, the provincial cancer programme for Alberta, Canada.
Quincy Chu
Medical oncologist, Cross Cancer Institute and University of Alberta, Edmonton
MesotheliomaLung cancerCanadian Cancer Trials Group studies
Edmonton oncologist who was lead author of KEYNOTE-483 (CCTG IND.227), the trial that showed adding pembrolizumab to chemotherapy lengthens survival in pleural mesothelioma.
Similar pages
- PersonKerry S. Courneya
Shares University of Alberta, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionThe Ottawa Hospital Cancer Centre / Ottawa Hospital Research Institute
Shares Canadian Cancer Trials Group (CCTG), Oncolytic viruses, Real-world evidence, HR-positive / HER2-negative breast cancer.
- PersonDongsheng Tu
Shares Canadian Cancer Trials Group (CCTG), Colorectal cancer.
- PersonWendy Parulekar
Shares Canadian Cancer Trials Group (CCTG), HR-positive / HER2-negative breast cancer.
- InstitutionQueen's University / Kingston Health Sciences Centre
Shares Canadian Cancer Trials Group (CCTG), Colorectal cancer.
- TargetGRPR (gastrin-releasing peptide receptor)
Shares PET (positron emission tomography), HR-positive / HER2-negative breast cancer.
- CompanyRefleXion Medical
Shares MR-guided adaptive radiotherapy, PET (positron emission tomography).
- PersonYuman Fong
Shares Oncolytic viruses, Colorectal cancer.